Indivior Pharmaceuticals Inc
(INDV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,188,000 | 1,093,000 | 901,000 | 791,000 | 647,000 |
| Cost of Goods | 231,000 | 174,000 | 159,000 | 127,000 | 97,000 |
| Gross Profit | 957,000 | 919,000 | 742,000 | 664,000 | 550,000 |
| Operating Expenses | 925,000 | 1,077,000 | 827,000 | 451,000 | 706,000 |
| Operating Income | 32,000 | -156,000 | -85,000 | 213,000 | -156,000 |
| Interest Expense | 41,000 | 35,000 | 29,000 | 27,000 | 26,000 |
| Other Income | 23,000 | 42,000 | 19,000 | 4,000 | 9,000 |
| Pre-tax Income | 14,000 | -149,000 | -95,000 | 190,000 | -173,000 |
| Income Tax | 11,000 | -20,000 | -42,000 | -15,000 | -25,000 |
| Net Income Continuous | 2,000 | -129,000 | -53,000 | 205,000 | -148,000 |
| Net Income | $2,000 | $-129,000 | $-53,000 | $205,000 | $-148,000 |
| EPS Basic Total Ops | 0.02 | -0.94 | -0.38 | 1.41 | -1.00 |
| EPS Basic Continuous Ops | 0.02 | -0.94 | -0.38 | 1.41 | -1.01 |
| EPS Diluted Total Ops | 0.02 | -0.94 | -0.38 | 1.35 | -1.00 |
| EPS Diluted Continuous Ops | 0.02 | -0.94 | -0.38 | 1.35 | -0.96 |
| EPS Diluted Before Non-Recurring Items | 1.66 | 1.57 | 1.16 | 0.90 | 0.40 |
| EBITDA(a) | $61,000 | $-143,000 | $-64,000 | $235,000 | $-130,000 |